127 related articles for article (PubMed ID: 29069502)
61. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
62. Prognostic factors for patients with microsurgically resected brain metastases.
Korinth MC; Delonge C; Hütter BO; Gilsbach JM
Onkologie; 2002 Oct; 25(5):420-5. PubMed ID: 12415195
[TBL] [Abstract][Full Text] [Related]
63. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
64. Is Karnofsky Performance Status Correlate with Better Overall Survival in Palliative Conformal Whole Brain Radiotherapy? Our Experience.
Reali A; Allis S; Girardi A; Verna R; Bianco L; Redda MG
Indian J Palliat Care; 2015; 21(3):311-6. PubMed ID: 26600700
[TBL] [Abstract][Full Text] [Related]
65. Radiotherapy for brain metastases: defining palliative response.
Bezjak A; Adam J; Panzarella T; Levin W; Barton R; Kirkbride P; McLean M; Mason W; Wong CS; Laperriere N
Radiother Oncol; 2001 Oct; 61(1):71-6. PubMed ID: 11578731
[TBL] [Abstract][Full Text] [Related]
66. Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels.
Nieder C; Marienhagen K; Dalhaug A; Norum J
ScientificWorldJournal; 2012; 2012():609323. PubMed ID: 22593701
[TBL] [Abstract][Full Text] [Related]
67. Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases.
Rades D; Hansen HC; Janssen S; Schild SE
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781513
[TBL] [Abstract][Full Text] [Related]
68. Palliative Radiotherapy for Leptomeningeal Carcinomatosis-Analysis of Outcome, Prognostic Factors, and Symptom Response.
El Shafie RA; Böhm K; Weber D; Lang K; Schlaich F; Adeberg S; Paul A; Haefner MF; Katayama S; Hörner-Rieber J; Hoegen P; Löw S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2018; 8():641. PubMed ID: 30671384
[No Abstract] [Full Text] [Related]
69. Prognostic Factors and Impact of Therapeutic Intervention in Patients With Brain Metastases at the Initial Presentation.
Ishikawa Y; Teramura S; Nakano H; Ito K; Yamada T
Cureus; 2024 May; 16(5):e60368. PubMed ID: 38751406
[TBL] [Abstract][Full Text] [Related]
70. Patients who die during palliative radiotherapy. Status survey.
Berger B; Ankele H; Bamberg M; Zips D
Strahlenther Onkol; 2014 Feb; 190(2):217-20. PubMed ID: 24408054
[TBL] [Abstract][Full Text] [Related]
71. Prognostic assessment of patients who receive radiotherapy for bone metastases from breast cancer.
Makita K; Kanzaki H; Hamamoto Y; Nagasaki K; Kataoka M; Kido T; Ohsumi S
Oncol Lett; 2023 May; 25(5):188. PubMed ID: 37065784
[TBL] [Abstract][Full Text] [Related]
72. Patterns of palliative radiotherapy fractionation for brain metastases patients in New South Wales, Australia.
Batumalai V; Descallar J; Delaney GP; Gabriel G; Wong K; Shafiq J; Vinod SK; Barton MB
Radiother Oncol; 2021 Mar; 156():174-180. PubMed ID: 33359268
[TBL] [Abstract][Full Text] [Related]
73. An Easy-To-Use Survival Score Compared to Existing Tools for Older Patients with Cerebral Metastases from Colorectal Cancer.
Rades D; Nguyen T; Janssen S; Schild SE
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235637
[TBL] [Abstract][Full Text] [Related]
74. Presentation and outcome in cancer patients with extensive spread to the brain.
Nieder C; Pawiniski A; Dalhaug A
BMC Res Notes; 2009 Dec; 2():247. PubMed ID: 20003374
[TBL] [Abstract][Full Text] [Related]
75. Survival after palliative radiotherapy of liver metastases. A search for prognostic factors.
Heimdal K; Hannisdal E; Fosså SD
Acta Oncol; 1988; 27(1):63-5. PubMed ID: 2452647
[TBL] [Abstract][Full Text] [Related]
76. Discontinuation of Palliative Brain Radiotherapy in Patients with Brain Metastases: A Case-Control Study.
Windisch P; Lütscher J; Förster R; Zwahlen DR; Schröder C
J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930133
[No Abstract] [Full Text] [Related]
77. Development of a score predicting survival after palliative reirradiation.
Nieder C; Andratschke N; Angelo K; Haukland E; Grosu AL
J Oncol; 2014; 2014():128240. PubMed ID: 25332718
[TBL] [Abstract][Full Text] [Related]
78. RETRACTED ARTICLE: Role of LDH as Prognostic Biochemical Marker for Breast Cancer Among Poor Patients, a Study at Rural Hospital.
Akther MJ; Nasar S; Khanam N
Indian J Surg; 2013 Jun; 75(3):250. PubMed ID: 24426443
[No Abstract] [Full Text] [Related]
79. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
[TBL] [Abstract][Full Text] [Related]
80. Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center.
Adegboyega B; Joseph A; Alabi A; Omomila J; Ngema LM; Ainsworth V; Chin J; Evbuomwan MO; Ngwa W
BMC Cancer; 2023 Dec; 23(1):1233. PubMed ID: 38098061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
